NEW YORK (GenomeWeb News) - Sloning Biotechnology has entered the synthetic gene-production market this month with an automated process, the company said today.
 
The company's technology, named Slonomics, will use a library of universal double-stranded DNA building blocks that the company will assemble with industrial robotic machines.
 
Additional details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.